Want to join the conversation?
Biopharmaceutical giant $GILD posted lower earnings in 2Q16 as a result of lower provision for income taxes. Net income was $3.5Bil or $2.58 per diluted share vs. $4.5Bil or $2.92 per diluted share in 2Q15. Non-GAAP diluted EPS excluding items was $3.08 for the quarter. Revenues fell 5.6% to $7.8Bil vs. 2Q15, hurt by lower anti-viral product sales.
Shareholder alert..!! Rosen Law Firm has commenced an investigation into potential securities claims of $UHS. Shareholders please visit http://www.rosenlegal.com/cases-1008.html for more info.
Can we see "Made in the USA" label on iPhones in the near future? Heard that $AAPL is considering the idea of manufacturing iPhone in America.
People who are looking for a steady growth stock should take a look at $EME. This stock has never had a significant downfall in the last five years. Comfortably beats consensus target most of the time. Such potential, much wow!
Looks like Creative Planning jumped on the bandwagon! Increased its stake by 91% in $EWBC. A lot of companies recently raised their stack too. I smell something’s cooking.
Hey $DIS, you are better off with Princess Cinderella and Prince Charming. Sports just ain’t your thing! Maybe it’s time you listened to investors about the ESPN separation!